Wave Life Sciences (WVE) Preferred Shares (2014)

Wave Life Sciences (WVE) posted Preferred Shares of $7.9 million for Q4 2014.

Wave Life Sciences (WVE) Preferred Shares (2014) Analysis & Trends

Wave Life Sciences' Preferred Shares history runs 1 years deep, the most recent figure standing at $7.9 million for Q4 2014.

Quarterly Preferred Shares changed N/A year-over-year to $7.9 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $7.9 million (changed N/A YoY) and the FY2014 annual result came in at $7.9 million, changed N/A from the prior year.
Preferred Shares was $7.9 million for Q4 2014 at Wave Life Sciences.
Across five years, Preferred Shares topped out at $7.9 million in Q4 2014 and bottomed at $7.9 million in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Wave Life Sciences	1.16 Bn	612.38 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	7.87 Mn